Cullinan Therapeutics, Inc. (CGEM)

Typically moves ±2.94% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Cullinan Therapeutics, Inc. (CGEM) has reported earnings 23 times since Mar 30, 2021. The stock moves an average of ±2.94% the day after reporting, closing higher 52.2% of the time. Its largest post-earnings gain was +6.7% (Aug 10, 2021) and its largest decline was -10.89% (May 15, 2024). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How CGEM moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±2.94%

Positive %

52.2%

Negative %

47.8%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	+1.96%	open_in_new
May 07, 2026	☀ PRE	-1.97%	open_in_new
Mar 10, 2026	☀ PRE	-2.61%	open_in_new
Nov 06, 2025	☀ PRE	+0.55%	open_in_new
Aug 07, 2025	☀ PRE	-10.79%	open_in_new
May 08, 2025	☀ PRE	+0.91%	open_in_new
Feb 27, 2025	☀ PRE	+1.89%	open_in_new
Nov 07, 2024	☀ PRE	-5.46%	open_in_new
Aug 08, 2024	☀ PRE	-0.97%	open_in_new
May 15, 2024	☽ POST	-10.89%	open_in_new
Mar 14, 2024	☀ PRE	-0.41%	open_in_new
Nov 08, 2023	☀ PRE	+0.81%	open_in_new
Aug 10, 2023	☀ PRE	-0.68%	open_in_new
May 11, 2023	☽ POST	+1.46%	open_in_new
Mar 09, 2023	☀ PRE	+0.09%	open_in_new
Nov 14, 2022	☀ PRE	+2.44%	open_in_new
Aug 10, 2022	☀ PRE	-0.85%	open_in_new
May 16, 2022	☀ PRE	+2.45%	open_in_new
Mar 17, 2022	☀ PRE	+4.57%	open_in_new
Nov 09, 2021	☀ PRE	-4.46%	open_in_new
Aug 10, 2021	☀ PRE	+6.7%	open_in_new
May 14, 2021	☀ PRE	-0.32%	open_in_new
Mar 30, 2021	☀ PRE	+4.42%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±2.94%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 22 →

Funds holding

$237215920

Total value held

Buying

17 added · 5 reduced

Blackrock, Inc.

$95288670 +17.59%

State Street Corp

$66805698 +44.20%

Goldman Sachs Group Inc

$18239100 +119.91%

Morgan Stanley

$11454726 +6.71%

Northern Trust Corp

$10399367 +27.12%

SEC Filing Types

description SCHEDULE 13G/A

10 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260908	open_in_new SEC.gov
4	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
144	20260813	open_in_new SEC.gov
8-K	20260813	open_in_new SEC.gov
SCHEDULE 13G	20260807	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
4	20260707	open_in_new SEC.gov

Frequently asked about CGEM earnings

When does Cullinan Therapeutics, Inc. report earnings next? expand_more

Cullinan Therapeutics, Inc. (CGEM)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CGEM stock move after earnings? expand_more

Over 23 reports, CGEM has moved an average of ±2.94% the session after earnings, closing higher 52.2% of the time.

What was CGEM's biggest post-earnings move? expand_more

CGEM's largest post-earnings gain on record was +6.7% on Aug 10, 2021, and its largest decline was -10.89% on May 15, 2024.

Where can I find Cullinan Therapeutics, Inc.'s SEC filings? expand_more

All of Cullinan Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.